Effects of simvastatin on the expression of inducible nitric oxide synthase and brain-derived neurotrophic factor in a lipopolysaccharide-induced rat model of Parkinson disease

References

• Antonini A, Cilia R. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Drug Saf 2009;32(6):475–88.
   PubMed Web of Science ®Google Scholar
• Félix-Redondo FJ, Grau M, Fernández-Bergés D. Cholesterol and cardiovascular disease in the elderly. Facts and Gaps. Aging Dis 2013;4(3):154–69.
   PubMed Web of Science ®Google Scholar
• Lemaitre RN, Psaty BM, Heckbert SR, et al. Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the cardiovascular health study. Arch Intern Med 2002:162:1395–400.
   PubMedGoogle Scholar
• The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549–59
   PubMed Web of Science ®Google Scholar
• Roberts CG, Guallar E, Rodriguez A. Efficacy and safety of statin monotherapy in older adults: a meta-analysis. J Gerontol Biol Sci Med Sci 2007;62:879–87.
   PubMed Web of Science ®Google Scholar
• Wang H, Lynch JR, Song P, et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 2007;206(1):59–69.
   PubMed Web of Science ®Google Scholar
• Keener A, Sanossian N. Niacin for stroke prevention: evidence and rationale. CNS Neurosci Ther 2008;14(4):287–94.
   PubMed Web of Science ®Google Scholar
• van der Most PJ, Dolga AM, Nijholt IM, et al. Statins: mechanisms of neuroprotection. Prog Neurobiol 2009;88(1):64–75.
   PubMed Web of Science ®Google Scholar
• Sugawara T, Ayer R, Jadhav V, et al. Mechanisms of statin treatment in cerebral vasospasm. Acta Neurochir Suppl 2011;110(Pt 2):9–11.
   PubMedGoogle Scholar
• Ayer RE, Ostrowski RP, Sugawara T, et al. Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage. Acta Neurochir Suppl 2013;115:259–66.
   PubMedGoogle Scholar
• Dolga AM, Nijholt IM, Ostroveanu A, et al. Lovastatin induces neuroprotection through tumor necrosis factor receptor 2 signaling pathways. J Alzheimers Dis 2008;13:111–122.
   PubMed Web of Science ®Google Scholar
• Sugawara T, Ayer R, Jadhav V, et al. Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase. J Neurosci Res 2008;86:3635–43.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yan JQ, Chen XH, et al. Statins: Multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol 2011;230:27–34.
   PubMed Web of Science ®Google Scholar
• Yan JQ, Xu YQ, Zhu CS, et al. Simvastatin prevents dopaminergic neurodegeneration in experimental Parkinsonian models: the association with anti-inflammatory responses. PLoS ONE 2011;6:e20945.
   PubMed Web of Science ®Google Scholar
• Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS Prog Neurobiol 1999;58(3):233–47.
   PubMed Web of Science ®Google Scholar
• Aloisi F. Immune function of microglia. Glia 2001;36(2):165–79.
   PubMed Web of Science ®Google Scholar
• Hirsch EC, Hunot S, Damier P, et al. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?. Ann Neurol 1998;44(3Suppl 1), S115–120.
   PubMedGoogle Scholar
• Mogi M, Kondo T, Mizuno Y, et al. P53 protein, interferon-gamma, and NF-kappa B levels are elevated in the Parkinsonian brain. Neurosci Lett 2007;414(1):94–7.
   PubMed Web of Science ®Google Scholar
• Sun S, Li H, Tong E, et al. Research on relation between Parkinson's disease and inflammatory reaction. Chinese J Neurol 2003;36:401–3.
   Google Scholar
• Kraft AD, Harry GJ. Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health 2011;8(7):2980–3018.
   PubMed Web of Science ®Google Scholar
• Li G, Sun SG, Cao XB, et al. LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats. J Huazhong Univ Sci Technol[Med Sci] 2004;24:83–6.
   PubMedGoogle Scholar
• Liberatore GT, Jackson-Lewis V, Vukosavic S, et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 1999;5(12):1403–9.
   PubMed Web of Science ®Google Scholar
• Iravani MM, Kashefi K, Mander P, et al. Involvement of inducible nitric oxide synthase in inflammatory-induced dopaminergic neurodegeneration. Neuroscience 2002;110(1):49–58.
   PubMed Web of Science ®Google Scholar
• Pan MQ, Gao HM, Long L, et al. Serum uric acid in patients with Parkinson's disease and vascular parkinsonism: A cross-sectional study. Neuroimmunomodulation 2013;20(1):19–28.
   PubMed Web of Science ®Google Scholar
• Selley ML. Simvastatin prevents 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice. Brain Res 2005;1037(1–2):1–6.
   PubMed Web of Science ®Google Scholar
• Xu YQ, Long L, Yan JQ, et al. Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses. CNS Neurosci Ther 2013;19(3):170–7.
   PubMed Web of Science ®Google Scholar
• Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004;22(3):123–31.
   PubMed Web of Science ®Google Scholar
• Wu S, Hua Q, Yang K et al. Research progress on brain-derived neurotrophic factors. Chinese J Clin 2013;7(9):3988–90.
   Google Scholar
• Howells DW, Porritt MJ, Wong JY, et al. Reduced BDNF mRNA expression in the Parkinson's disease substantia Nigra. Exp Neurol 2000;166(1):127–35.
   PubMed Web of Science ®Google Scholar
• Hernández-Romero MC, Argüelles S, Villarán RF, et al. Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide [J]. J Neurochem 2008;105(2):445–59.
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhao Y. Research progress on relation between brain-derived neurotrophic factors and Parkinson's disease. Chinese J Gerontol 2011;31(2):527–30.
   Google Scholar
• Zhang LM, Yan JQ, Xu YQ, et al. The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular Parkinsonism. PLoS One 2011;6:e19333.
   PubMed Web of Science ®Google Scholar
• Pfeiffer RF. Parkinson disease nonmotor symptoms in Parkinson disease: the PRIAMO study. Nat Rev Neurol 2009;5:531–2.
   PubMed Web of Science ®Google Scholar
• Xu YQ, Yan JQ, Zhou P, et al. Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2012;97:1–13.
   PubMed Web of Science ®Google Scholar
• Barco A, Patterson S, Alarcon JM, et al. Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Neuron 2005;48:123–37.
   PubMed Web of Science ®Google Scholar
• Patterson SL, Abel T, Deuel TA, et al. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996;16:1137–45.
   PubMed Web of Science ®Google Scholar
• Tyler WJ, Alonso M, Bramham CR, et al. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 2002;9:224–37.
   PubMed Web of Science ®Google Scholar
• Messaoudi E, Ying SW, Kanhema T, et al. Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 2002;22:7453–61.
   PubMed Web of Science ®Google Scholar
• Patterson SL, Pittenger C, Morozov A, et al. Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron 2001;32:123–40.
   PubMed Web of Science ®Google Scholar
• Hall J, Thomas KL, Everitt BJ. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 2000;3:533–5.
   PubMed Web of Science ®Google Scholar
• Ma YL, Wang HL, Wu HC, et al. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats. Neuroscience 1998;82:957–67.
   PubMed Web of Science ®Google Scholar
• Mizuno M, Yamada K, Olariu A, et al. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci 2000;20:7116–21.
   PubMed Web of Science ®Google Scholar
• Bramham CR, Worley PF, Moore MJ, et al. The immediate early gene Arc/Arg3.1: regulation, mechanisms, and function. J Neurosci 2008;28(46):11760–7.
   PubMed Web of Science ®Google Scholar
• Barrientos RM, Frank MG, Watkins LR, et al. Memory impairments in healthy aging: role of aging-induced microglial sensitization. Aging Dis 2010;1(3):212–31.
   PubMed Web of Science ®Google Scholar
• Jang SW, Liu X, Pradoldej S, et al. N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci U S A 2010;107:3876–81.
   PubMed Web of Science ®Google Scholar
• Tosini G, Ye K, Iuvone PM. N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain. NEUROSCIENTIST 2012;18:645–53.
   PubMed Web of Science ®Google Scholar
• Sompol P, Liu X, Baba K, et al. N-acetylserotonin promotes hippocampal neuroprogenitor cell proliferation in sleep-deprived mice. Proc Natl Acad Sci U S A 2011;108:8844–9.
   PubMed Web of Science ®Google Scholar
• Yoo DY, Nam SM, Kim W, et al. N-Acetylserotonin increases cell proliferation and differentiating neuroblasts with tertiary dendrites through upregulation of brain-derived neurotrophic factor in the mouse dentate gyrus. J Vet Med Sci 2011;73(11):1411–6.
   PubMed Web of Science ®Google Scholar
• Oxenkrug G, Ratner R. N-Acetylserotonin and aging-associated cognitive impairment and depression. Aging Dis 2012;3(4):330–8.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wei X, Gao H, et al. Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced Parkinsonian rats: the association with improvements in long-term memory. Neuroscience 2014;267:57–66.
   PubMed Web of Science ®Google Scholar
• Becker C, Jick SS, Meier CR. Use of statins and the risk of Parkinson's disease—A retrospective case-control study in the UK. Drug Saf 2008;31(5):399–407.
   PubMed Web of Science ®Google Scholar
• Danbolt NC. Glutamate uptake. Prog Neurobiol 2001;65(1):1–105.
   PubMed Web of Science ®Google Scholar
• Pralong E, Magistretti P, Stoop R. Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders. Prog Neurobiol 2002;67(3):173–202.
   PubMed Web of Science ®Google Scholar
• Piccini P, Pavese N, Brooks DJ. Endogenous dopamine release after pharmacological challenges in Parkinson's disease. Ann Neurol 2003;53(5):647–53.
   PubMed Web of Science ®Google Scholar
• Cheesman AL, Barker RA, Lewis SJ, et al. Lateralisation of striatal function: evidence from F-18-dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatr 2005;76(9):1204–10.
   PubMed Web of Science ®Google Scholar
• Sawamoto N, Piccini P, Hotton G, et al. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 2008;131:1294–302.
   PubMed Web of Science ®Google Scholar
• Huot P, Fox SH, Brotchie JM. The serotonergic system in Parkinson's disease. Prog Neurobiol 2011;95(2):163–212.
   PubMed Web of Science ®Google Scholar
• Lee YC, Lin CH, Wu RM, et al. Discontinuation of statin therapy associates with Parkinson disease: a population-based study. Neurology 2013;81(5):410–6.
   PubMed Web of Science ®Google Scholar
• Gao X, Simon KC, Schwarzschild MA, et al. Prospective study of statin use and risk of Parkinson disease. Arch Neurol 2012;69(3):380–4.
   PubMed Web of Science ®Google Scholar